PTAB finds claims directed to a spinal fusion implant unpatentable

February 20, 2015 – In two related inter partes review decisions, the PTAB found that NuVasive, Inc.’s U.S. Patent Nos. 8,361,156 and 8,187,334 directed to a spinal implant and methods of spinal fusion using the implant unpatentable as obvious.  The cases are captioned Medtronic, Inc. v. NuVasive, Inc., IPR2013-00506 and -507.

By:  Christopher J. Stankus


View Attachment (PDF)